Glutathione and Oxidized Low-Density Lipoprotein as Biomarkers of Oxidative Stress in Essential Hypertension
Keywords:
Essential hypertension, Glutathione, Oxidized low-density lipoprotein, Oxidative stress, Reactive oxygen speciesAbstract
OBJECTIVE: This study aimed to compare the serum levels of Glutathione and Oxidized Low-Density Lipoprotein in early hypertensive and normotensive subjects and to evaluate the diagnostic accuracy of these biomarkers for detecting oxidative stress in essential hypertension.
METHODOLOGY: An analytical cross-sectional study was conducted at Civil (Dr. Ruth K.M. Pfau) Hospital Karachi from July 2020 to March 2021 after approval from the ethical committee. After informed consent, the serum oxidized low-density lipoprotein and glutathione levels were measured with ELISA's help in 40 normotensive and 40 early hypertensive participants. The results were analyzed by SPSS 21, keeping a significant p-value at <0.05.
RESULTS: The median levels of Oxidized Low-Density Lipoprotein were higher in hypertensive than in normotensive (i.e. 31.47 ng/ml vs. 15.27 ng/ml). The median levels of glutathione were also raised in hypertensive compared with normotensive(i.e. 15.69 ng/ml vs. 4.46 ng/ml). The differences were significant (p-value <0.001). Both markers showed adequate diagnostic accuracy, sensitivity and specificity to detect oxidative stress in early hypertension.
CONCLUSION: Oxidized Low-Density Lipoproteins are raised in early hypertension, endorsing the detrimental role of oxidative stress, while the levels of glutathione are increased to compensate for and combat increased oxidative stress in early hypertension. These biomarkers can be utilized clinically to discern the burden of oxidative stress in early hypertension.
References
Lee HY. New definition for hypertension. J Korean Med Assoc. 2018;61(8):485-92. doi: 10.5124/jkma.2018.61.8.485.
Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour LM et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019.J Am CollCardiol.2020; 76 (25): 2982-3021.doi: 10.1016/j.jacc.2020.11.010.
Kong AS-Y, Lai KS, Hee C-W, Loh JY, Lim SHE, Sathiya M. Oxidative Stress Parameters as Biomarkers of Cardiovascular Disease towards the Development and Progression.Antioxidants(Basel). 2022; 11(6):1175. doi: 10.3390/antiox110 61175.
Sies H, Berndt C, Jones DP. Oxidative Stress. Annu Rev Biochem. 2017;86(1):715-48. doi: 10.1146/annurev-biochem-061516-045037. Epub 2017 Apr 24.
Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol. 2015;31(5):631-41. doi: 10.1016/j. cjca.2015.02.008. Epub 2015 Feb 14.
Strimbu K, Tavel JA. What are biomarkers.CurrOpin HIV AIDS. 2010;5(6):463-6. doi: 10.1097/COH.0b013e32833ed177.
Panda P, Verma HK, Lakkakula S, Merchant N, Kadir F, Rahman S et al. Biomarkers of oxidative stress tethered to cardiovascular diseasesOxid Med Cell Longev. 2022; 2022: 9154295. doi: 10.1155/2022/9154295.
Levitan I, Volkov S, Subbaiah PV. Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal. 2010;13(1):39-75. doi: 10.1089/ars.2009.2733.
Dinh QN, Chrissobolis S, Diep H, Chan CT, Ferens D, Drummond GR et al. Advanced atherosclerosis is associated with inflammation, vascular dysfunction and oxidative stress, but not hypertension. Pharmacol Res. 2017;116:70-76. doi: 10.1016/j.phrs.2016.12.032. Epub 2016 Dec 23.
Khan A, Iqbal Z. A clinical study showing altered antioxidants profile in patients with hypertension. Pak J Pharm Sci. 2018;31(1):9-18.
Shere A, Eletta O, Goyal H. Circulating blood biomarkers in essential hypertension: a literature review. J Lab Precis Med. 2017;2(12):1-11.
doi: 10.21037/jlpm.2017.12.06.
Trpkovic A, Resanovic I, Stanimirovic J, Radak D, Mousa SA, Cenic-Milosevic D et al. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci. 2015;52(2):70-85. doi: 10.3109/10408363.2014. 992063. Epub 2014 Dec 24.
Frostegård J, Wu R, Lemne C, Thulin T, Witztum JL, de Faire U. Circulating oxidized low-density lipoprotein is increased in hypertension. ClinSci(Lond). 2003;105(5):615-20. doi: 10.1042/CS2003 0152.
Asadpour PM, Pordal A-H, Beyranvand M-R. Measurement of oxidized low-density lipoprotein and superoxide dismutase activity in patients with hypertension. Arch Iran Med. 2009;12(2):116-20.
Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP, Calo LA. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm. 2013;2013: 714653.doi: 10.1155/2013/714653. Epub 2013 Oct 3. http://doi.org/10.1155/2013/714653
Kuklinska AM, Mroczko B, Musial WJ, Usowicz-Szarynska M, Sawicki R, Borowska H et al. Diagnostic biomarkers of essential arterial hypertension: the value of prostacyclin, nitric oxide, oxidized-LDL, and peroxide measurements. Int Heart J. 2009;50(3):341-51. doi: 10.1536/ihj. 50.341.
Muda P, Kampus P, Zilmer M, Zilmer K, Kairane C, RistimaeT et al. Homocysteine and red blood cell glutathione as indices for middle-aged untreated essential hypertension patients. J Hypertens.2003; 21(12):2329-33. doi: 10.1097/00 004872-200312000-00022.
Nwanjo H, Oze G, Okafor M, Nwosu D, Nwankpa P. Oxidative stress and non-enzymic antioxidant status in hypertensive patients in Nigeria. Afr J Biotechnol. 2007; 6(14):1681-84.
Razzaq A, Iqbal I, Lateef HF. Analysis of level of antioxidants in the prognosis of hypertension patients in Pakistan. Int J AdvBiotechnol Res. 2018; 9(2):735-8.
Rybka J, Kupczyk D, K?dziora-Kornatowska K, Motyl J, Czuczejko J, Szewczyk-Golec K. Glutathione-related antioxidant defense system in elderly patients treated for hypertension. CardiovascToxicol. 2011; 11(1): 1-9. doi: 10.1007/s12012-010-9096-5.
Daiber A, Hahad O, Andreadou I, Steven S, Daub S, Münzel T. Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond. Redox Biol. 2021; 42: 101875. doi: 10.1016/j.redox.2021.101875. Epub 2021 Jan 23.
Verma MK, Jaiswal A, Sharma P, Kumar P, Singh AN. Oxidative stress and biomarker of TNF-?, MDA and FRAP in hypertension. J Med Life.2019; 12(3): 253-259. doi: 10.25122/jml-2019-0031.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
